Production (Stage)
Capricor Therapeutics, Inc.
CAPR
$12.38
$0.605.09%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.39M | -7.12M | -12.56M | -11.00M | -9.79M |
| Total Depreciation and Amortization | 405.50K | 375.70K | 361.20K | 356.90K | 331.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.87M | 2.39M | 2.04M | 2.14M | 3.26M |
| Change in Net Operating Assets | 11.68M | -10.45M | -1.49M | -3.79M | 4.94M |
| Cash from Operations | -6.43M | -14.80M | -11.64M | -12.29M | -1.27M |
| Capital Expenditure | -1.14M | -734.70K | -59.00K | -80.90K | -664.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.03M | -122.65M | 2.06M | 14.78M | -8.84M |
| Cash from Investing | 23.89M | -123.38M | 2.00M | 14.70M | -9.50M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 50.40K | 81.09M | 67.33M | 2.07M | 2.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.40K | 81.09M | 67.33M | 2.07M | 2.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.51M | -57.09M | 57.69M | 4.47M | -8.48M |